Malog, Nurisa .
HRN: 27-93-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/11/2025
CEFTRIAXONE 1G (VIAL)
10/11/2025
10/18/2025
IVT
2g
Q24
Postpartum Cardiomegaly, Postpartum Eclampsiap
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes